BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$725M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$694M |
| 3 |
Microsoft
MSFT
|
+$320M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$216M |
| 5 |
Amazon
AMZN
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$153M |
| 2 |
Bank of America
BAC
|
+$130M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$62.1M |
| 4 |
STJ
St Jude Medical
STJ
|
+$55.6M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$50.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.95% |
| 2 | Financials | 11.02% |
| 3 | Healthcare | 9.12% |
| 4 | Communication Services | 8.65% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Acadia Pharmaceuticals
ACAD
$4.89B
| $657K | ﹤0.01% |
19,099
-3,352
| -15% | -$118K |
|
1552
LPL Financial
LPLA
$29.5B
| $655K | ﹤0.01% |
16,439
+8,483
| +107% | +$333K |
|
1553
CALL
SLB Ltd
SLB
$77.3B
| $655K | ﹤0.01% |
6,631
+868
| +15% | +$71K |
|
|
MORE
1554
DELISTED
Monogram Residential Trust, Inc.
MORE
| $652K | ﹤0.01% |
65,377
-4,535
| -6% | -$46.3K |
|
1555
Companhia Siderúrgica Nacional
SID
$1.19B
| $651K | ﹤0.01% |
223,036
+56,664
| +34% | +$206K |
|
1556
CALL
PepsiCo
PEP
$192B
| $650K | ﹤0.01% |
2,215
-2,146
| -49% | -$230K |
|
|
APC
1557
PUT
DELISTED
Anadarko Petroleum
APC
| $650K | ﹤0.01% |
3,189
+282
| +10% | +$18.8K |
|
1558
Healthcare Services Group
HCSG
$1.45B
| $646K | ﹤0.01% |
14,990
-1,132
| -7% | -$46.5K |
|
|
MDSO
1559
DELISTED
Medidata Solutions, Inc.
MDSO
| $644K | ﹤0.01% |
11,171
+997
| +10% | +$53.9K |
|
|
ACH
1560
Accendra Health
ACH
$84.6M
| $642K | ﹤0.01% |
18,556
-7,605
| -29% | -$272K |
|
|
CMCM
1561
Cheetah Mobile
CMCM
$94.7M
| $641K | ﹤0.01% |
11,933
+1,665
| +16% | +$86.4K |
|
|
LPNT
1562
DELISTED
LifePoint Health, Inc.
LPNT
| $637K | ﹤0.01% |
9,728
-3,847
| -28% | -$238K |
|
1563
Spire
SR
$4.9B
| $636K | ﹤0.01% |
9,428
-969
| -9% | -$63.1K |
|
1564
Neurocrine Biosciences
NBIX
$15.3B
| $635K | ﹤0.01% |
14,665
+1,890
| +15% | +$81K |
|
1565
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $633K | ﹤0.01% |
9,522
+1,405
| +17% | +$94.8K |
|
|
JUNO
1566
DELISTED
Juno Therapeutics, Inc.
JUNO
| $632K | ﹤0.01% |
28,481
+8,150
| +40% | +$175K |
|
|
SPN
1567
DELISTED
Superior Energy Services, Inc.
SPN
| $628K | ﹤0.01% |
4,405
-1,229
| -22% | -$202K |
|
1568
CALL
Lockheed Martin
LMT
$138B
| $628K | ﹤0.01% |
819
+145
| +22% | +$38K |
|
|
AAN.A
1569
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $626K | ﹤0.01% |
21,044
-7,112
| -25% | -$212K |
|
1570
CALL
HP
HPQ
$28.6B
| $626K | ﹤0.01% |
5,866
+5,835
| +18,823% | +$94.4K |
|
|
CAA
1571
DELISTED
CalAtlantic Group, Inc.
CAA
| $625K | ﹤0.01% |
16,691
-5,916
| -26% | -$209K |
|
1572
Darling Ingredients
DAR
$10.4B
| $624K | ﹤0.01% |
43,006
+5,209
| +14% | +$68.6K |
|
|
CHL
1573
DELISTED
China Mobile Limited
CHL
| $620K | ﹤0.01% |
11,225
+6,005
| +115% | +$335K |
|
1574
Synaptics
SYNA
$4.2B
| $620K | ﹤0.01% |
12,519
-10,343
| -45% | -$556K |
|
1575
PUT
Blackrock
BLK
$183B
| $618K | ﹤0.01% |
666
-53
| -7% | -$20.3K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2017 Portfolio in Review
As of Q1 2017, BNP Paribas Financial Markets held 4,403 positions worth $37.9B, up 77% from $21.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $14.9B of net new capital in Q1 2017, opening 244 new positions and adding to 1,412 existing holdings. Its largest new stake was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $153M trimmed.
- BNP Paribas Financial Markets's largest Q1 2017 buy was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
- BNP Paribas Financial Markets added most to Apple in Q1 2017, an estimated $725M increase.
- BNP Paribas Financial Markets's biggest Q1 2017 reduction was iShares US Real Estate ETF, cutting an estimated $153M.
- BNP Paribas Financial Markets fully exited St Jude Medical in Q1 2017, selling an estimated $55.6M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $37.9B portfolio in Q1 2017.
- BNP Paribas Financial Markets opened 244 new positions and closed 335 in Q1 2017.
- BNP Paribas Financial Markets's portfolio value rose 77% quarter-over-quarter to $37.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2017, filed 3 May 2017.